发明名称 FUSED HETEROCYCLIC COMPOUND AND MEDICINAL USE THEREOF
摘要 <p>The fused heterocyclic compound of the present invention, which is represented by the formula (I): &lt;CHEM&gt; wherein each symbol is as defined in the specification, an optically active form thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a water adduct thereof show poly(ADP-ribose) synthase inhibitory action and are useful as therapeutic drugs for cerebral infarction.</p>
申请公布号 EP1396488(A1) 申请公布日期 2004.03.10
申请号 EP20020726463 申请日期 2002.05.23
申请人 MITSUBISHI PHARMA CORPORATION 发明人 FUJIO, MASAKAZU;SATOH, HIROYUKI;NUMATA, ATSUSHI;TAKANASHI, SHINICHI;EGI, YASUHIRO;TATSUMI, RYOU
分类号 A61K31/4365;A61K31/4375;A61K31/472;A61K31/4725;A61K31/473;A61K31/496;A61K31/517;A61K31/5377;A61K31/55;A61K31/551;A61P3/10;A61P7/04;A61P9/10;A61P25/00;A61P25/14;A61P25/28;A61P29/00;A61P43/00;C07D217/24;C07D239/90;C07D401/04;C07D451/02;C07D453/02;C07D471/04;(IPC1-7):C07D217/24 主分类号 A61K31/4365
代理机构 代理人
主权项
地址